Sugi Predict

Sugi Predict / Compounds / SCHEMBL3582168

SCHEMBL3582168

SCHEMBL3582168

Oc1ccc(Cl)cc1-n1nc2ccccc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.65
▸ RAB9A P51151 3/20 0.65
▸ LMNA P02545 2/20 0.65
▸ IDO1 P14902 3/20 0.46
▸ KCNMA1 Q12791 2/20 0.43
▸ HSD17B10 Q99714 3/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HPGD P15428 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ POLB P06746 2/20 0.39
▸ ALOX15 P16050 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ TDO2 P48775 1/20 0.38
▸ IDO2 Q6ZQW0 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11418479 0.89 NPC1 (0.51) NPC1RAB9ALMNAIDO1KCNMA1
SCHEMBL29814234 0.84 NPC1 (0.57) NPC1RAB9ALMNAHSD17B10TSHR
SCHEMBL563001 0.84 NPC1 (0.57) NPC1RAB9ALMNAHSD17B10TSHR
SCHEMBL29377081 0.83 POLB (0.50) NPC1RAB9ALMNAIDO1KCNMA1
SCHEMBL3782539 0.83 POLB (0.50) NPC1RAB9ALMNAIDO1KCNMA1
SCHEMBL3624606 0.82 NPC1 (0.52) NPC1RAB9ALMNAIDO1KCNMA1
SCHEMBL1702661 0.82 LMNA (0.49) NPC1RAB9ALMNAKCNMA1HSD17B10
SCHEMBL30337840 0.81 NPC1 (0.69) NPC1RAB9ALMNAKCNMA1MEN1
SCHEMBL7857203 0.81 NPC1 (0.69) NPC1RAB9ALMNAKCNMA1MEN1
SCHEMBL3579429 0.80 LMNA (0.49) NPC1RAB9ALMNAIDO1KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087468-A1 MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION METABOLEX, INC. (US) 2010-04-08 — — US disclosed
US-20100087468-A1 MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION METABOLEX, INC. (US) 2010-04-08 — — US disclosed
US-20100087468-A1 MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION METABOLEX, INC. (US) 2010-04-08 — — US disclosed
US-7642358-B2 Substituted phenylacetic acids METABOLEX, INC. (US) 2010-01-05 — — US disclosed
US-7642358-B2 Substituted phenylacetic acids METABOLEX, INC. (US) 2010-01-05 — — US disclosed
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 — — US disclosed
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 — — US disclosed
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 — — US disclosed
EP-1776111-A2 MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION METABOLEX, INC. (US) 2007-04-25 — — EP disclosed
US-20060058301-A1 Modulators of PPAR and methods of their preparation METABOLEX, INC. (US) 2006-03-16 — — US disclosed
EP-0099231-A2 Polyphenylene ether resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1984-01-25 — — EP disclosed
US-4173599-A 2,2,6,6-Tetraalkyl-4-piperidyl ketones and ketals as stabilizers for synthetic polymers ARGUS CHEMICAL CORPORATION (US) 1979-11-06 — — US disclosed
US-4128559-A ANTIDEPRESSANT EASTMAN KODAK COMPANY (US) 1978-12-05 — — US disclosed
US-4115476-A 2,2,6,6-Tetramethyl-4-piperidyl carbonic acid esters of dihydric alcohols and phenols as stabilizers for synthetic polymers ARGUS CHEMICAL CORPORATION (US) 1978-09-19 — — US disclosed
US-4089839-A STABILIZERS/AGENTS UNIROYAL, INC. (US) 1978-05-16 — — US disclosed
US-4065427-A Polychromophoric heterocyclic ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1977-12-27 — — US disclosed
US-4041011-A FOR POLYMERS EASTMAN KODAK COMPANY (US) 1977-08-09 — — US disclosed
US-4000148-A POLYMERS EASTMAN KODAK COMPANY (US) 1976-12-28 — — US disclosed
US-3978074-A CATALYTIC HYDROGENATION UNIROYAL INC. (US) 1976-08-31 — — US disclosed
US-3936418-A Benzotriazole ortho-ester ultraviolet stabilizers and their use in organic compositions EASTMAN KODAK COMPANY (US) 1976-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087468-A1 MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION PPARG, PPARD, PPARA NPC1 204/4885RAB9A 3393/4885LMNA 1997/4885
US-20060058301-A1 Modulators of PPAR and methods of their preparation PPARG, PPARD, PPARA NPC1 204/4885RAB9A 3393/4885LMNA 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.